Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 7.45B 1.11B 990M 918M 835M 1.58B 106B 1.6B 11.03B 4.32B 55.16B 4.18B 4.09B 176B P/E 2026 *
16.5x
P/E 2027 * 13.9x
Enterprise Value 6.21B 929M 825M 765M 696M 1.31B 88.13B 1.33B 9.2B 3.61B 45.99B 3.49B 3.41B 147B EV / Sales 2026 *
0.35x
EV / Sales 2027 * 0.32x
Free-Float
51.88%
Yield 2026 *
2.78%
Yield 2027 * 3.8%
1 day+1.49%
1 week+18.11%
Current month+21.08%
1 month+20.97%
3 months+14.66%
6 months+3.84%
Current year+0.93%
1 week 10.95
Extreme 10.95
13.1
1 month 10.58
Extreme 10.58
13.1
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
14.8
3 years 9.41
Extreme 9.41
26.45
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 22/11/2023
President 60 25/11/2019
Director of Finance/CFO 44 22/11/2023
Director TitleAgeSince
Chairman 60 01/06/2009
Chairman 61 01/06/2009
Director/Board Member 44 16/11/2016
Date Insider Type Main position Quantity % Market Cap. Importance
5/12/26 A Buy

Founder

1,359,000 0.3397%
5/12/26 A Sell

Founder

-2,727,600 0.6818%
5/11/26 A Sell

Founder

-8,806,300 2.2012%
Change 5-day change 1-year change 3-year change Capi.($)
+1.49%+18.11%-6.35%-41.48% 1.11B
+2.17%+6.87%-36.53%+3.10% 15.67B
+12.04%-4.19%+7.11%-24.18% 7.07B
+1.47%+3.93%-11.49%+4.70% 6.34B
+0.43%+2.77%-12.18%-2.43% 6.34B
+1.52%+5.07%-49.24%-38.04% 6.19B
-3.17%+4.28%+1.54%-10.77% 4.54B
-1.25%+12.01%-34.35%-2.11% 3.41B
+0.26%+1.03%-14.03%-10.40% 3.24B
-0.69%-0.80%+6.34%-22.43% 3.17B
Average +1.43%+3.91%-14.92%-14.41% 5.71B
Weighted average by Cap. +2.14%+3.89%-19.61%-9.64%

Financials

2026 *2027 *
Net sales 17.57B 2.63B 2.33B 2.16B 1.97B 3.71B 249B 3.77B 26.01B 10.2B 130B 9.86B 9.65B 415B 18.59B 2.78B 2.47B 2.29B 2.08B 3.93B 264B 3.99B 27.51B 10.79B 138B 10.42B 10.2B 439B
Net income 456M 68.18M 60.6M 56.17M 51.1M 96.44M 6.47B 97.98M 675M 265M 3.38B 256M 250M 10.76B 547M 81.71M 72.63M 67.32M 61.25M 116M 7.75B 117M 809M 317M 4.05B 307M 300M 12.9B
Net Debt -1.24B -185M -165M -153M -139M -262M -17.57B -266M -1.83B -719M -9.17B -695M -680M -29.23B -1.42B -213M -189M -175M -159M -301M -20.19B -306M -2.11B -826M -10.54B -799M -782M -33.59B
Projected Income Statement - Annual - Yixintang Pharmaceutical Group Co., Ltd.
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
16/10/26 CN¥12.98 +1.49% 32,459,026
15/10/26 CN¥12.79 +2.65% 34,925,816
14/10/26 CN¥12.46 +5.95% 33,122,819
13/10/26 CN¥11.76 +1.03% 18,755,326
12/10/26 CN¥11.64 +5.91% 19,899,097
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Yixintang Pharmaceutical Group Co., Ltd.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
12.98CNY
Average target price
13.19CNY
Spread / Average Target
+1.62%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Yixintang Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002727 Stock